Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11840) 11840
Book Chapter (230) 230
Newsletter (226) 226
Newspaper Article (202) 202
Magazine Article (19) 19
Dissertation (15) 15
Book / eBook (14) 14
Conference Proceeding (7) 7
Reference (5) 5
Trade Publication Article (5) 5
Transcript (5) 5
Book Review (3) 3
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
multiple sclerosis (10453) 10453
science & technology (9734) 9734
life sciences & biomedicine (9092) 9092
humans (8764) 8764
neurosciences & neurology (6397) 6397
female (5960) 5960
male (5344) 5344
adult (5161) 5161
neurosciences (4824) 4824
clinical neurology (4726) 4726
neurology (4305) 4305
middle aged (4094) 4094
magnetic resonance imaging (3451) 3451
multiple sclerosis - pathology (2885) 2885
biological and medical sciences (2550) 2550
medical sciences (2519) 2519
brain - pathology (2186) 2186
animals (2172) 2172
multiple sclerosis and variants. guillain barré syndrome and other inflammatory polyneuropathies. leukoencephalitis (1957) 1957
immunology (1791) 1791
disease progression (1432) 1432
research (1395) 1395
multiple sclerosis - immunology (1260) 1260
inflammation (1258) 1258
multiple sclerosis, relapsing-remitting - pathology (1256) 1256
young adult (1245) 1245
multiple sclerosis - physiopathology (1136) 1136
multiple sclerosis - drug therapy (1103) 1103
nervous system (1099) 1099
aged (1068) 1068
care and treatment (1035) 1035
magnetic resonance imaging - methods (1022) 1022
adolescent (1015) 1015
multiple sclerosis - diagnosis (1010) 1010
analysis (1005) 1005
neuroimaging (997) 997
mice (978) 978
patients (963) 963
brain (928) 928
central nervous system (897) 897
development and progression (894) 894
multiple sclerosis - complications (893) 893
demyelination (876) 876
disability evaluation (876) 876
autoimmune diseases (841) 841
radiology, nuclear medicine & medical imaging (806) 806
multiple sclerosis, relapsing-remitting - drug therapy (797) 797
abridged index medicus (795) 795
medicine & public health (785) 785
medicine (783) 783
pathology (777) 777
studies (742) 742
atrophy (733) 733
health aspects (728) 728
diagnosis (719) 719
case-control studies (718) 718
research article (715) 715
medical research (712) 712
nuclear magnetic resonance--nmr (709) 709
mri (708) 708
risk factors (707) 707
multiple sclerosis - metabolism (697) 697
disease (687) 687
treatment outcome (684) 684
neurodegeneration (668) 668
cytokines (664) 664
science & technology - other topics (636) 636
autoimmunity (633) 633
multidisciplinary sciences (628) 628
disease models, animal (626) 626
severity of illness index (622) 622
t cells (609) 609
degenerative and inherited degenerative diseases of the nervous system. leukodystrophies. prion diseases (604) 604
psychiatry (603) 603
multiple sclerosis - genetics (591) 591
review (586) 586
lymphocytes (585) 585
spinal cord - pathology (581) 581
cell biology (580) 580
experimental autoimmune encephalomyelitis (575) 575
encephalomyelitis, autoimmune, experimental - immunology (558) 558
multiple sclerosis - therapy (557) 557
biomarkers (544) 544
proteins (538) 538
interferon (537) 537
science (533) 533
usage (523) 523
encephalomyelitis, autoimmune, experimental - pathology (519) 519
spinal cord (514) 514
time factors (507) 507
follow-up studies (505) 505
physiological aspects (502) 502
neuroradiology (491) 491
clinical trials (486) 486
recurrence (485) 485
mice, inbred c57bl (481) 481
pathogenesis (480) 480
immune system (479) 479
medicine, experimental (476) 476
drug therapy (473) 473
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (3) 3
Faculty of Information - Cataloguing (1) 1
OISE - Theses (1) 1
Online Resources - Online (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12475) 12475
French (39) 39
Spanish (29) 29
German (28) 28
Russian (26) 26
Portuguese (17) 17
Japanese (10) 10
Polish (7) 7
Turkish (6) 6
Italian (4) 4
Chinese (2) 2
Hungarian (2) 2
Norwegian (2) 2
Dutch (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
by Hauser, Stephen L and Waubant, Emmanuelle and Arnold, Douglas L and Vollmer, Timothy and Antel, Jack and Fox, Robert J and Bar-Or, Amit and Panzara, Michael and Sarkar, Neena and Agarwal, Sunil and Langer-Gould, Annette and Smith, Craig H and HERMES Trial Grp and HERMES Trial Group
The New England journal of medicine, ISSN 0028-4793, 02/2008, Volume 358, Issue 7, pp. 676 - 688
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Gadolinium | Male | Immunoglobulins - blood | Adult | Female | B-Lymphocytes - metabolism | Multiple Sclerosis, Relapsing-Remitting - pathology | Antibodies, Monoclonal, Murine-Derived | Antigens, CD20 | Multiple Sclerosis, Relapsing-Remitting - immunology | Double-Blind Method | Multiple Sclerosis, Relapsing-Remitting - drug therapy | Antibodies, Monoclonal - pharmacology | Rituximab | Remission Induction | B-Lymphocytes - drug effects | Magnetic Resonance Imaging | B-Lymphocytes - immunology | Adolescent | Brain - pathology | Immunologic Factors - adverse effects | Infusions, Intravenous | Immunologic Factors - pharmacology | Immunologic Factors - therapeutic use | Causes of | B cells | Drug therapy | Health aspects | Sclerosis | Disability | Multiple sclerosis | Cytokines | Lymphocytes | Patients | Immune system | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Rituximab in relapsing‐remitting multiple sclerosis: A 72‐week, open‐label, phase I trial
by Bar‐Or, Amit and Calabresi, Peter A. J and Arnold, Douglas and Markowitz, Clyde and Shafer, Stuart and Kasper, Lloyd H and Waubant, Emmanuelle and Gazda, Suzanne and Fox, Robert J and Panzara, Michael and Sarkar, Neena and Agarwal, Sunil and Smith, Craig H
Annals of neurology, ISSN 0364-5134, 03/2008, Volume 63, Issue 3, pp. 395 - 400
Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neurology | Biological and medical sciences | Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis | Medical sciences | Multiple Sclerosis, Relapsing-Remitting - pathology | Antibodies, Monoclonal, Murine-Derived | Multiple Sclerosis, Relapsing-Remitting - immunology | Multiple Sclerosis, Relapsing-Remitting - drug therapy | Humans | Middle Aged | Magnetic Resonance Imaging - methods | Rituximab | Antibodies, Monoclonal - therapeutic use | Male | Lymphocyte Depletion | Time Factors | Adult | Female | B-Lymphocytes - pathology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Inclusion of brain volume loss in a revised measure of ‘no evidence of disease activity’ (NEDA-4) in relapsing–remitting multiple sclerosis
by Kappos, Ludwig and De Stefano, Nicola and Freedman, Mark S and Cree, Bruce AC and Radue, Ernst-Wilhelm and Sprenger, Till and Sormani, Maria Pia and Smith, Terence and Häring, Dieter A and Piani Meier, Daniela and Tomic, Davorka
Multiple sclerosis, ISSN 1352-4585, 9/2016, Volume 22, Issue 10, pp. 1297 - 1305
Atrophy | NEDA | brain | fingolimod | multiple sclerosis | Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Brain - diagnostic imaging | Multiple Sclerosis, Relapsing-Remitting - drug therapy | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Organ Size | Male | Treatment Outcome | Young Adult | Magnetic Resonance Imaging | Clinical Trials, Phase III as Topic | Multiple Sclerosis, Relapsing-Remitting - diagnostic imaging | Adolescent | Brain - pathology | Adult | Female | Fingolimod Hydrochloride - therapeutic use | Multiple sclerosis | Index Medicus | Original Research Papers
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
by Kappos, Ludwig, Prof and Li, David, MD and Calabresi, Peter A, MD and O'Connor, Paul, MD and Bar-Or, Amit, MD and Barkhof, Frederik, Prof and Yin, Ming, PhD and Leppert, David, MD and Glanzman, Robert, MD and Tinbergen, Jeroen, MD and Hauser, Stephen L, Prof
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9805, pp. 1779 - 1787
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Neurology | Biological and medical sciences | General aspects | Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis | Medical sciences | Interferon-beta - administration & dosage | Antibodies, Monoclonal, Humanized - adverse effects | Multiple Sclerosis, Relapsing-Remitting - immunology | Double-Blind Method | Drug Administration Schedule | Multiple Sclerosis, Relapsing-Remitting - drug therapy | Humans | Gadolinium | Male | Multiple Sclerosis, Relapsing-Remitting - diagnosis | B-Lymphocytes - drug effects | Magnetic Resonance Imaging | Antibodies, Monoclonal, Humanized - administration & dosage | Contrast Media | Interferon-beta - adverse effects | Brain - pathology | Adult | Female | Infusions, Intravenous | Multiple sclerosis | Monoclonal antibodies | Physiological aspects | Research | Diagnosis | B cells | Drug therapy | Health aspects | Data collection | Medical research | Cytotoxicity | Clinical medicine | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Large-scale neuronal network dysfunction in relapsing-remitting multiple sclerosis
by Rocca, Maria A and Valsasina, Paola and Martinelli, Vittorio and Misci, Paolo and Falini, Andrea and Comi, Giancarlo and Filippi, Massimo
Neurology, ISSN 0028-3878, 10/2012, Volume 79, Issue 14, pp. 1449 - 1457
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neurology | Biological and medical sciences | Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis | Medical sciences | Disability Evaluation | Multiple Sclerosis, Relapsing-Remitting - pathology | Neural Pathways - blood supply | Brain - physiopathology | Humans | Middle Aged | Male | Statistics as Topic | Neural Pathways - pathology | Nerve Net - pathology | Oxygen - blood | Young Adult | Brain - blood supply | Magnetic Resonance Imaging | Analysis of Variance | Image Processing, Computer-Assisted | Brain Mapping | Adult | Female | Nerve Net - blood supply | Principal Component Analysis | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text B cells as a therapeutic target for IFN-β in relapsing-remitting multiple sclerosis
by Ramgolam, Vinod S and Sha, Yonggang and Marcus, Karen L and Choudhary, Neelima and Troiani, Luigi and Chopra, Manisha and Markovic-Plese, Silva
The Journal of immunology (1950), ISSN 0022-1767, 04/2011, Volume 186, Issue 7, pp. 4518 - 4526
Life Sciences & Biomedicine | Immunology | Science & Technology | Adjuvants, Immunologic - physiology | Multiple Sclerosis, Relapsing-Remitting - immunology | B-Lymphocyte Subsets - pathology | Multiple Sclerosis, Relapsing-Remitting - therapy | Coculture Techniques | Dendritic Cells - immunology | Humans | Cells, Cultured | Interferon-beta - physiology | Lymphocyte Culture Test, Mixed | B-Lymphocyte Subsets - metabolism | Interferon beta-1a | Interleukin-23 - antagonists & inhibitors | Interleukin-23 - biosynthesis | B-Lymphocyte Subsets - immunology | Interleukin-1beta - biosynthesis | Drug Delivery Systems - methods | Dendritic Cells - metabolism | Multiple Sclerosis, Relapsing-Remitting - metabolism | Interleukin-1beta - antagonists & inhibitors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Ibudilast in relapsing-remitting multiple sclerosis A neuroprotectant?
by Barkhof, F and Hulst, H.E and lovic, J and Uitdehaag, B.M.J and Matsuda, K and Landin, R and MN 166-001 Investigators and MN166-001 Investigators and For the MN166-001 Investigators
Neurology, ISSN 0028-3878, 2010, Volume 74, Issue 13, pp. 1033 - 1040
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neurology | Biological and medical sciences | Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis | Medical sciences | Disability Evaluation | Multiple Sclerosis, Relapsing-Remitting - pathology | Neuroprotective Agents - therapeutic use | Recurrence | Pyridines - administration & dosage | Double-Blind Method | Multiple Sclerosis, Relapsing-Remitting - drug therapy | Humans | Multiple Sclerosis, Chronic Progressive - pathology | Organ Size | Male | Treatment Outcome | Disease Progression | Magnetic Resonance Imaging | Pyridines - adverse effects | Brain - pathology | Adult | Female | Neuroprotective Agents - adverse effects | Neuroprotective Agents - administration & dosage | Multiple Sclerosis, Chronic Progressive - drug therapy | Pyridines - therapeutic use | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Basal ganglia and frontal/parietal cortical atrophy is associated with fatigue in relapsing—remitting multiple sclerosis
by Calabrese, Massimiliano and Rinaldi, Francesca and Grossi, Paola and Mattisi, Irene and Bernardi, Valentina and Favaretto, Alice and Perini, Paola and Gallo, Paolo
Multiple sclerosis, ISSN 1352-4585, 10/2010, Volume 16, Issue 10, pp. 1220 - 1228
Atrophy | fatigue | MRI | multiple sclerosis | Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neurology | Biological and medical sciences | Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis | Medical sciences | Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases | Fatigue - pathology | Natalizumab | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Fatigue - etiology | Glatiramer Acetate | Antibodies, Monoclonal - therapeutic use | Male | Young Adult | Antibodies, Monoclonal, Humanized | Psychiatric Status Rating Scales | Cognition - physiology | Adult | Female | Multiple Sclerosis, Relapsing-Remitting - complications | Disability Evaluation | Multiple Sclerosis, Relapsing-Remitting - pathology | Fatigue - psychology | Basal Ganglia - pathology | Parietal Lobe - pathology | Magnetic Resonance Imaging | Image Processing, Computer-Assisted | Multiple Sclerosis, Relapsing-Remitting - psychology | Adolescent | Depression - psychology | Frontal Lobe - pathology | Peptides - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Oral simvastatin treatment in relapsing-remitting multiple sclerosis
by Vollmer, Timothy and Key, Lyndon and Durkalski, Valerie and Tyor, William and Corboy, John and Markovic-Plese, Silva and Preiningerova, Jana and Rizzo, Marco and Singh, Inderjit
The Lancet (British edition), ISSN 0140-6736, 2004, Volume 363, Issue 9421, pp. 1607 - 1608
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Neurology | Biological and medical sciences | General aspects | Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis | Medical sciences | Adjuvants, Immunologic - administration & dosage | Administration, Oral | Multiple Sclerosis, Relapsing-Remitting - drug therapy | Simvastatin - administration & dosage | Humans | Middle Aged | Gadolinium | Male | Multiple Sclerosis, Relapsing-Remitting - diagnosis | Magnetic Resonance Imaging | Contrast Media | Adolescent | Brain - pathology | Adult | Female | Evaluation | Multiple sclerosis | Drug therapy | Simvastatin | Anticholesteremic agents | Prescription drugs | Medical treatment | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Peripheral oxidative stress in relapsing–remitting multiple sclerosis
by Tasset, Inmaculada and Agüera, Eduardo and Sánchez-López, Fernando and Feijóo, Montserrat and Giraldo, Ana I and Cruz, Antonio H and Gascón, Félix and Túnez, Isaac
Clinical biochemistry, ISSN 0009-9120, 04/2012, Volume 45, Issue 6, pp. 440 - 444
Antioxidant system | Oxidative stress | Multiple sclerosis | Glutathione redox system | Global oxidative stress | Life Sciences & Biomedicine | Medical Laboratory Technology | Science & Technology | Neurology | Biological and medical sciences | Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis | Investigative techniques, diagnostic techniques (general aspects) | Medical sciences | Multiple Sclerosis, Relapsing-Remitting - pathology | Deoxyguanosine - blood | Protein Carbonylation | Multiple Sclerosis, Relapsing-Remitting - blood | Oxidation-Reduction | Oxidative Stress | Humans | Middle Aged | Male | Biomarkers - blood | Blood Proteins - metabolism | Oxidoreductases - blood | Adult | Female | Deoxyguanosine - analogs & derivatives | Glutathione - blood | Antioxidants | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights